U.S. Smoking Deaths May Be Underestimated, Study Suggests

WEDNESDAY, Feb. 11, 2015 (HealthDay News) -- Smoking may be killing more people than even current estimates indicate, a new study suggests.

Lower Blood Pressure Reduces First Stroke Risk: Study

WEDNESDAY, Feb. 11, 2015 (HealthDay News) -- Keeping the top number in a blood pressure reading below 140 helps reduce the risk of stroke in healthy people 60 and older, according to a new study.

Iron Supplements May Help Blood Donors Recover More Quickly

TUESDAY, Feb. 10, 2015 (HealthDay News) -- Low-dose iron supplements speed blood donors' recovery of iron and hemoglobin, an iron-rich protein that carries oxygen in red blood cells, new research shows.

Blood Pressure Meds Lower Heart, Stroke Risks in Diabetics: Analysis

TUESDAY, Feb. 10, 2015 (HealthDay News) -- A new analysis shows that people with type 2 diabetes are less likely to suffer heart attacks, strokes or die early when they take blood pressure medications -- even if they don't actually have high blood pressure.

Health Tip: Understanding Low Blood Pressure

(HealthDay News) -- Hypotension, or low blood pressure, can occur for a variety of reasons and may cause lightheadedness or dizziness.

Preterm Delivery Linked to Heart Disease, Stroke Risk in Mothers

TUESDAY, Feb. 10, 2015 (HealthDay News) -- Women who have a preterm baby may face an increased risk of heart disease and stroke, a preliminary study suggests.

Loved Ones Caring for Brain-Injured Veterans May Face Health Risks

MONDAY, Feb. 9, 2015 (HealthDay News) -- Some loved ones who care for veterans with brain injuries may be at increased risk for chronic health problems, a new study indicates.

Lucentis Approved for Diabetic Retinopathy

MONDAY, Feb. 9, 2015 (HealthDay News) -- A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.

Energy Drinks Tied to Inattention, Hyper Behavior in Middle Schoolers: Study

MONDAY, Feb. 9, 2015 (HealthDay News) -- Energy drinks are linked to hyperactivity and inattention in middle-school students, a new study reveals.

FDA Approves 1st Drug for Diabetic Retinopathy

FRIDAY, Feb. 6, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the drug Lucentis (ranibizumab) to treat diabetic retinopathy in patients with diabetic macular edema.